A federal appeals court won't upend Morrisville-based Liquidia's loss in a patent dispute with United Therapeutics that threatens to stall the U.S. launch of Liquidia's Yutrepia treatment for pulmonary arterial hypertension.
By Dean Seal A federal appeals court won't upend Liquidia's loss in a patent dispute with United Therapeutics that threatens to stall the U.S. launch of.
insurancenewsnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from insurancenewsnet.com Daily Mail and Mail on Sunday newspapers.